InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Amman Bradford K., Chief Financial Officer. Director active across 1 companies, notably Vivos Therapeutics, Inc.. In total, 2 disclosures have been recorded. Total volume traded: €9k. The latest transaction was disclosed on 25 May 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€4,3191,000 shares@ €4.3187100.0% of flow
Common Stock
SEC:0001493152-21-012902·
Ideal exit: 19 Feb 2022 (T+270)
€4,3191,000 shares@ €4.31870.049% mcap50.0% of flow
Common Stock
SEC:0001493152-21-012902:0·
Ideal exit: 19 Feb 2022 (T+270)
2 of 2 declarations
About Amman Bradford K.
Bradford K. Amman is the Chief Financial Officer at Vivos Therapeutics, Inc. He is responsible for the financial management of the company, including financial planning and risk management. His role is essential in ensuring the financial health and sustainable growth of the organization.
